|

VANDA PHARMACEUTICALS INC (VNDA)

US9216591084 - Common Stock

3.9  +0.18 (+4.84%)

After market: 4 +0.1 (+2.56%)

TTM
(2023-9-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
CASH FLOWS FROM OPERATING ACTIVITIES
Net Income
11.80M6.30M33.20M23.30M115.60M
Depreciation Amortization
2.50M2.70M2.90M2.90M2.90M
Income Taxes - Deferred
6.60M1.10M6.70M6.20M-87.80M
Change In Working Capital
-4.90M6.10M2.70M4.30M3.10M
Other non cash items
10.00M15.80M18.70M15.10M12.10M
OPERATING CASH FLOW
25.90M32.00M64.20M51.80M45.90M
 
CASH FLOWS FROM INVESTING ACTIVITIES
Capital Expenditure
-400.00K-700.00K-600.00K-1.80M-1.00M
Other Investing Activity
107.60M50.60M-76.10M-39.70M-67.30M
INVESTING CASH FLOW
107.10M49.90M-76.70M-41.50M-68.30M
 
CASH FLOWS FROM FINANCING ACTIVITIES
Stock Issued/Repurchased
N/A700.00K3.60M5.60M6.30M
Other Financing Activity
N/AN/AN/AN/AN/A
FINANCING CASH FLOW
N/A700.00K3.60M5.60M6.30M
 
Exchange Rate Effect
100.00K300.00K-100.00K100.00K0.00
CHANGE IN CASH
133.70M82.90M-9.00M16.00M-16.10M
 
FREE CASH FLOW
Operating Cash Flow
25.90M32.00M64.20M51.80M45.90M
Capital Expenditure
-400.00K-700.00K-600.00K-1.80M-1.00M
FREE CASH FLOW
25.50M31.30M63.60M50.00M44.90M

All data in USD

Charts